Study of the Mechanism of Antiviral Activity of Cytovir®-3 Against Respiratory Viruses In Vitro
Антибиотики и Химиотерапия, 2023 Introduction. The requirements of modern clinical guidelines for the treatment of respiratory viral infections suggest the possibility of identifying a specific viral pathogen.
V. V. Zarubaev +6 more
doaj +1 more source
The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
Infectious Disease and Therapy, 2021 Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults.
J. Domachowske +2 more
semanticscholar +1 more source
Human Vaccines & Immunotherapeutics, 2021 To date, there is no consensus regarding palivizumab prophylaxis for respiratory syncytial virus infection. The purpose of this study is to assess the effectiveness of palivizumab prophylaxis to prevent respiratory syncytial virus-related infection ...
Natividad Viguria +5 more
doaj +1 more source
Current State of Respiratory Syncytial Virus Disease and Management
Infectious Disease and Therapy, 2021 Respiratory syncytial virus (RSV) is a major cause of hospitalizations due to pneumonia and bronchiolitis. Substantial morbidity and socioeconomic burden are associated with RSV infection worldwide.
A. Chatterjee, K. Mavunda, L. Krilov
semanticscholar +1 more source
RSV infection and recurrence of respiratory tract obstruction in children
Pediatria i Medycyna Rodzinna, 2016 Viruses, including the respiratory syncytial virus, are the most common aetiological factor of respiratory infections in children. The disease most often occurs between November and April in the northern climate zone, with a peak incidence in January ...
Karolina Kapusta +2 more
doaj +1 more source
Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults [PDF]
, 2022 Background. Respiratory syncytial virus (RSV) causes a substantial burden in older adults. Viral load in RSV-infected adults is generally lower compared to young children, which could result in suboptimal sensitivity of RSV diagnostics.
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
core
An update on respiratory syncytial virus
BMC Infectious Diseases, 2023 AbstractRespiratory syncytial virus (RSV) is a leading cause of acute respiratory infections resulting in a significant burden worldwide, particularly in children and older adults. This collection calls for original research papers that advance our understanding of the epidemiology, evolution, diagnosis, clinical management, and prevention of RSV ...
Antonio Piralla +2 more
openaire +3 more sources
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. [PDF]
, 2015 Respiratory syncytial virus (RSV) is a globally prevalent cause of lower respiratory infection in neonates and infants. Despite its disease burden, a safe and effective RSV vaccine has remained elusive.
Giersing, Birgitte +5 more
core +1 more source
Viral etiology of acute respiratory infections in hospitalized children in Novosibirsk City, Russia (2013 - 2017). [PDF]
PLoS ONE, 2018 BACKGROUND:Acute respiratory infections (ARIs) cause a considerable morbidity and mortality worldwide especially in children. However, there are few studies of the etiological structure of ARIs in Russia. In this work, we analyzed the etiology of ARIs in
Olga Kurskaya +11 more
doaj +1 more source
Identification of group B respiratory syncytial viruses that lack the 60-nucleotide duplication after six consecutive epidemics of total BA dominance at coastal Kenya [PDF]
, 2013 Respiratory syncytial virus BA genotype has reportedly replaced other group B genotypes worldwide. We report the observation of three group B viruses, all identical in G sequence but lacking the BA duplication, at a coastal district hospital in Kenya in ...
Agoti, Charles N. +4 more
core +1 more source